HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Experience in treating metabolic osteopathies with 1 alpha-hydroxyvitamin D3 (oksidevit)].

Abstract
The action of 1 alpha-hydroxycholecalciferol (oxydevit) was estimated in 204 patients with renal osteodystrophy, osteoporosis of varying etiology, osteomalacia because of malabsorption, congenital rickets-like diseases. The drug was shown to be highly effective in the treatment of secondary hyperparathyroidism in uremia, steroidal and senile osteoporosis. The treatment involved replacement therapy.
AuthorsD A Babarykin, N A Reĭsner, A N Riabukha, R L Rozental'
JournalTerapevticheskii arkhiv (Ter Arkh) Vol. 63 Issue 11 Pg. 113-6 ( 1991) ISSN: 0040-3660 [Print] Russia (Federation)
Vernacular TitleOpyt lecheniia metabolicheskikh osteopatiĭ 1 al'fa-gidroksivitaminom D3 (oksidevitom).
PMID1810042 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Hydroxycholecalciferols
  • alfacalcidol
Topics
  • Bone Diseases, Metabolic (drug therapy, metabolism)
  • Drug Evaluation
  • Female
  • Humans
  • Hydroxycholecalciferols (therapeutic use)
  • Osteomalacia (drug therapy, metabolism)
  • Osteoporosis (drug therapy, metabolism)
  • Osteoporosis, Postmenopausal (drug therapy, metabolism)
  • Rickets (congenital, drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: